Click here to read about some of the people we've helped.  We're here to help you, too. Get four essential health reports by joining our e-news community.

Four FREE health reports for you

Register now for our vital and insightful health updates, and get four free health reports to help you live more healthily.

First Name:Email:


Antidepressants: They’re not as effective as we’re told after researchers suppress the ‘bad’ studies

Doctors and the public may have been misled about the effectiveness of antidepressant drugs.  They have both been victims of spin that researchers have put on their findings in order to present the drugs in the best possible light.

Sometimes poor results have been suppressed, while even those that have been published have claimed the drug is far more effective than the findings suggest, new research has discovered.

In virtually every case, the drug trial has been paid for by the manufacturer, researchers from Oregon Health and Science University found.

They analysed 74 separate trials into antidepressant drugs that had been registered with America’s Food and Drug Administration (FDA).  Of these, a third was never published, and this was usually because the study discovered the drug was either not effective or was more dangerous than first thought.

Of the trials that were published, 94 per cent of them came up with a positive outcome about the effectiveness of the drug, and yet the FDA’s independent analysis of the same trials concluded that just half were positive.

(Source: New England Journal of Medicine, 2008; 358: 252-60).

Click here to receive health news by email.
WDDTY Blog Speak

Fda to doctors: open up or else - America's health regulator, the Food and Drug Administration (FDA), has been trying for 20 years to get doctors to share more information about drugs...

Fda drug alerts - Crestor (rosuvastatin): The US Food and Drug Administration (FDA) has issued a Public Health Advisory notifying healthcare professionals that 22 membe...

Fda fingers heart drug - The calcium blocker nifedipine used to treat high blood pressure has been singled out by the US's Food and Drug Administration (FDA) for increasing th...

Hrt: need for better trials - The benefits of hormone replacement therapy could be cancelled out by their risks, according to an editorial in the New England Journal of Medicine. ....

Drugs or Nothing: New FDA policy targets practitioners who offer an alternative - There seems to be a sea change in the enforcement policy of America’s health watchdog, the Food and Drug Administration (FDA). It’s targeting more al...

Antidepressant linked with withdrawal symptoms - For years, drug manufacturing giant GlaxoSmithKline has promoted their best-selling antidepressant paroxetine (Seroxat) as safe and easy to quit takin...

Drug Controls: The FDA tries to get tough - America’s drug regulator, the Food and Drug Administration (FDA), is finally trying to toughen up its act.

Medical fascism - Recently, the New England Journal of Medicine devoted a good portion of an issue to chiropractic. The first study, which purported to examine whether...